Translational Development Acquisition Corp.
Translational Development Acquisition Corp. (TDAC) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001673481 · TDAC · NASDAQ · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001673481 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Translational Development Acquisition Corp. (NASDAQ: TDAC) has submitted 463 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2025. As a Financial Services sector company with CIK 0001673481, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Translational Development Acquisition Corp.'s most comprehensive regulatory disclosure. The most recent Translational Development Acquisition Corp. 10-K was filed on 2025-05-13 for fiscal year ending 2025. Historical TDAC 10-K annual reports are available from 2016 through 2025.
Investors researching Translational Development Acquisition Corp. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
TDAC SEC Filings · 8 questionsTranslational Development Acquisition Corp. (TDAC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 463 filings and access original documents at no cost. Translational Development Acquisition Corp.'s CIK is 0001673481.